At a glance
- Originator Ube Industries
- Class Antidementias; Antidepressants; Neuroprotectants
- Mechanism of Action Acetylcholinesterase inhibitors; Adrenergic receptor antagonists; Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 04 Oct 2001 No-Development-Reported for Alzheimer's disease in Japan (unspecified route)
- 18 Aug 1999 Preclinical development for Alzheimer's disease in Japan (unspecified route)